|
1
|
Wadekar JB, Sawant RL and Patal UB:
Rheumatoid arthritis and herbal drugs: A review. The J
Phytopharmacol. 4:311–318. 2015.
|
|
2
|
Bullock J, Rizvi SAA, Saleh AM, Ahmed SS,
Do DP, Ansari RA and Ahmed J: Rheumatoid arthritis: A brief
overview of the treatment. Med Princ Pract. 27:501–507.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhang Q, Liu Q, Lin C, Baima Y, Li H, Gong
H and Lin J: The prevalence of rheumatoid arthritis in middle-aged
and elderly people living in Naqu City, Tibet, Autonomous Region of
China. J Orthop Surg Res. 15(338)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Nygaard G and Firestein GS: Restoring
synovial homeostasis in rheumatoid arthritis by targeting
fibroblast-like synoviocytes. Nat Rev Rheumatol. 16:316–333.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ
and Xu J: Rheumatoid arthritis: Pathological mechanisms and modern
pharmacologic therapies. Bone Res. 6(15)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Conforti A, di Cola I, Pavlych V, Ruscitti
P, Berardicurti O, Ursini F, Giacomelli R and Cipriani P: Beyond
the joints, the extra-articular manifestations in rheumatoid
arthritis. Autoimmun Rev. 20(102735)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yu HC and Lu MC: The roles of
anti-citrullinated protein antibodies in the immunopathogenesis of
rheumatoid arthritis. Tzu Chi Med J. 31:5–10. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Scherer HU, Häupl T and Burmester GR: The
etiology of rheumatoid arthritis. J Autoimmun.
110(102400)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sharma SD, Leung SH and Viatte S: Genetics
of rheumatoid arthritis. Best Pract Res Clin Rheumatol.
38(101968)2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shi J, van de Stadt LA, Levarht EW,
Huizinga TW, Hamann D, van Schaardenburg D and Trouw LA:
Anti-carbamylated protein (anti-CarP) antibodies precede the onset
of rheumatoid arthritis. Ann Rheum Dis. 73:780–783. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Deane KD, Demoruelle MK, Kelmenson LB,
Kuhn KA, Norris JM and Holers VM: Genetic and environmental risk
factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol.
31:3–18. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gregersen PK, Silver J and Winchester RJ:
The shared epitope hypothesis. An approach to understanding the
molecular genetics of susceptibility to rheumatoid arthritis.
Arthritis Rheum. 30:1205–1213. 1987.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang HG, McDermott G, Seyok T, Huang S,
Dahal K, L'Yi S, Lea-Bonzel C, Stratton J, Weisenfeld D, Monach P,
et al: Identifying shared genetic architecture between rheumatoid
arthritis and other conditions: A phenome-wide association study
with genetic risk scores. EBioMedicine. 92(104581)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sogkas G and Witte T: The link between
rheumatic disorders and inborn errors of immunity. EBioMedicine.
90(104501)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Arnson Y, Shoenfeld Y and Amital H:
Effects of tobacco smoke on immunity, inflammation and
autoimmunity. J Autoimmun. 34:J258–J265. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Turner S and Cherry N: Rheumatoid
arthritis in workers exposed to silica in the pottery industry.
Occup Environ Med. 57:443–447. 2000.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pattison DJ, Symmons DP, Lunt M, Welch A,
Luben R, Bingham SA, Khaw KT, Day NE and Silman AJ: Dietary risk
factors for the development of inflammatory polyarthritis: Evidence
for a role of high level of red meat consumption. Arthritis Rheum.
50:3804–3812. 2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gan RW, Demoruelle MK, Deane KD, Weisman
MH, Buckner JH, Gregersen PK, Mikuls TR, O'Dell JR, Keating RM,
Fingerlin TE, et al: Omega-3 fatty acids are associated with a
lower prevalence of autoantibodies in shared epitope-positive
subjects at risk for rheumatoid arthritis. Ann Rheum Dis.
76:147–152. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kurkó J, Besenyei T, Laki J, Glant TT,
Mikecz K and Szekanecz Z: Genetics of rheumatoid arthritis-a
comprehensive review. Clin Rev Allergy Immunol. 45:170–179.
2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Laragione T, Harris C, Azizgolshani N,
Beeton C, Bongers G and Gulko PS: Magnesium increases numbers of
Foxp3+ Treg cells and reduces arthritis severity and joint damage
in an IL-10-dependent manner mediated by the intestinal microbiome.
EBioMedicine. 92(104603)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Auréal M, Machuca-Gayet I and Coury F:
Rheumatoid arthritis in the view of osteoimmunology. Biomolecules.
11(48)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kondo N, Kuroda T and Kobayashi D:
Cytokine networks in the pathogenesis of rheumatoid arthritis. Int
J Mol Sci. 22(10922)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yazici Y and Simsek I: The 2010 ACR/EULAR
rheumatoid arthritis classification criteria: How are they
performing in the clinic? Rheumatology. 51 (Suppl 6):vi5–vi9.
2012.
|
|
24
|
Felson DT, Smolen JS, Wells G, Zhang B,
van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J,
Bombardieri S, et al: American College of Rheumatology/European
League Against Rheumatism provisional definition of remission in
rheumatoid arthritis for clinical trials. Arthritis Rheum.
63:573–586. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Firestein GS and McInnes IB:
Immunopathogenesis of rheumatoid arthritis. Immunity. 46:183–196.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
de la Guardia C, Rangel G, Villarreal A,
Goodridge A, Fernández PL and Lleonart R: Development of in-house,
indirect ELISAs for the detection of SARS-CoV-2 spike
protein-associated serology in COVID-19 patients in Panama. PLoS
One. 16(e0257351)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Govindarajan R, Duraiyan J, Kaliyappan K
and Palanisamy M: Microarray and its applications. J Pharm
Bioallied Sci. 4 (Suppl 2):S310–S312. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gao Y, Zhang Y and Liu X: Rheumatoid
arthritis: Pathogenesis and therapeutic advances. MedComm (2020).
5(e509)2024.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Villa Mde G, Jiménez-Jorquera C, Haro I,
Gomara MJ, Sanmartí R, Fernández-Sánchez C and Mendoza E: Carbon
nanotube composite peptide-based biosensors as putative diagnostic
tools for rheumatoid arthritis. Biosens Bioelectron. 27:113–118.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Fernández-Sánchez C, Pellicer E, Orozco J,
Jiménez-Jorquera C, Lechuga LM and Mendoza E: Plasma-activated
multi-walled carbon nanotube-polystyrene composite substrates for
biosensing. Nanotechnology. 20(335501)2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Šenolt L, Grassi W and Szodoray P:
Laboratory biomarkers or imaging in the diagnostics of rheumatoid
arthritis? BMC Med. 12(49)2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Soós L, Szekanecz Z, Szabó Z, Fekete A,
Zeher M, Horváth IF and Lakos G: Clinical evaluation of
anti-mutated citrullinated vimentin by ELISA in rheumatoid
arthritis. J Rheumatol. 34:1658–1663. 2007.PubMed/NCBI
|
|
33
|
McInnes IB and Schett G: The pathogenesis
of rheumatoid arthritis. N Engl J Med. 365:2205–2219.
2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cojocaru M, Cojocaru IM, Silosi I, Vrabie
CD and Tanasescu R: Extra-articular manifestations in rheumatoid
arthritis. Maedica (Bucur). 5:286–291. 2010.PubMed/NCBI
|
|
35
|
Janeway CA Jr, Travers P, Walport M and
Shlomchik MJ: B-cell activation by armed helper T cells. In:
Immunobiology: The Immune System in Health and Disease. 5th
edition. Garland Science, 2001.
|
|
36
|
Curran AM, Naik P, Giles JT and Darrah E:
PAD enzymes in rheumatoid arthritis: Pathogenic effectors and
autoimmune targets. Nat Rev Rheumatol. 16:301–315. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
van Drongelen V and Holoshitz J:
HLA-disease associations in rheumatoid arthritis. Rheum Dis Clin
North Am. 43:363–376. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kurowska W, Kuca-Warnawin EH, Radzikowska
A and Maśliński W: The role of anti-citrullinated protein
antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Cent
Eur J Immunol. 42:390–398. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Malemud CJ: Matrix metalloproteinases and
synovial joint pathology. Prog Mol Biol Transl Sci. 148:305–325.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
McInnes IB and Schett G: Pathogenetic
insights from the treatment of rheumatoid arthritis. Lancet.
389:2328–2337. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Markusse IM, Dirven L, Gerards AH, van
Groenendael JH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW and
Allaart CF: Disease flares in rheumatoid arthritis are associated
with joint damage progression and disability: 10-year results from
the BeSt study. Arthritis Res Ther. 17(232)2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Frauwirth KA and Thompson CB: Activation
and inhibition of lymphocytes by costimulation. J Clin Investig.
109:295–299. 2002.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chang CK, Chen PK, Chen CC, Chang SH, Chen
CH and Chen DY: Increased levels of omega-3 fatty acids and DHA are
linked to pain reduction in rheumatoid arthritis patients treated
with janus kinase inhibitors. Nutrients. 13(3050)2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Trieb K and Hofstaetter SG: Treatment
strategies in surgery for rheumatoid arthritis. Eur J Radiol.
71:204–210. 2009.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Qureshi O and Dua A: COX Inhibitors. In:
StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL,
2019.
|
|
46
|
Coutinho AE and Chapman KE: The
anti-inflammatory and immunosuppressive effects of glucocorticoids,
recent developments and mechanistic insights. Mol Cell Endocrinol.
335:2–13. 2011.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Bywall KS, Kihlbom U, Hansson M, Falahee
M, Raza K, Baecklund E and Veldwijk J: Patient preferences on
rheumatoid arthritis second-line treatment: A discrete choice
experiment of Swedish patients. Arthritis Res Ther.
22(288)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Fraenkel L, Bathon JM, England BR, St
Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK,
Kerr G, et al: 2021 American College of Rheumatology guideline for
the treatment of rheumatoid arthritis. Arthritis Rheumatol.
73:1108–1123. 2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Kartnig F, Bonelli M, Goldmann U, Mészáros
N, Krall N, Aletaha D, Heinz LX and Superti-Furga G: Ex vivo
imaging-based high content phenotyping of patients with rheumatoid
arthritis. EBioMedicine,. 111(105522)2025.PubMed/NCBI View Article : Google Scholar
|
|
50
|
He M, Hu Z and Yang M: Effects of total
glucosides of paeony on serum inflammatory cytokines in animal
models of rheumatoid arthritis: A systematic review and
meta-analysis. Front Pharmacol. 15(1349259)2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Nalwa HS, Prasad P, Ganguly NK, Chaturvedi
V and Mittal SA: Methotrexate intolerance in rheumatoid arthritis.
Transl med commun. 8(10)2023.
|
|
52
|
Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro
N, Tanaka Y, Yamanaka H, Kamatani N, Harigai M, Ryu J, Inoue K, et
al: Postmarketing surveillance of the safety profile of infliximab
in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis.
67:189–194. 2008.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Deane KD: Can rheumatoid arthritis be
prevented? Best Pract Res Clin Rheumatol. 27:467–485.
2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Burmester GR, Feist E and Dörner T:
Emerging cell and cytokine targets in rheumatoid arthritis. Nat Rev
Rheumatol. 10:77–88. 2014.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Tanaka Y, Maeshima Y and Yamaoka K: In
vitro and in vivo analysis of a JAK inhibitor in rheumatoid
arthritis. Ann Rheum Dis. 71 (Suppl 2):i70–i74. 2012.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wu KK: Aspirin and other cyclooxygenase
inhibitors: new therapeutic insights. Semin Vasc Med. 3:107–112.
2003.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Wang F, Sun L, Wang S, Davis JM III,
Matteson EL, Murad MH, Luo F and Vassallo R: Efficacy and safety of
tofacitinib, baricitinib, and upadacitinib for rheumatoid
arthritis: A systematic review and meta-analysis. Mayo Clin Proc.
95:1404–1419. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Al Maashari R and Hamodat MM:
Methotrexate-induced panniculitis in a patient with rheumatoid
arthritis. Acta Dermatovenerol Alp Pannonica Adriat. 25:79–81.
2016.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Volin MV, Campbell PL, Connors MA,
Woodruff DC and Koch AE: The effect of sulfasalazine on rheumatoid
arthritic synovial tissue chemokine production. Exp Mol Pathol.
73:84–92. 2002.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Liu D, Ahmet A, Ward L, Krishnamoorthy P,
Mandelcorn ED, Leigh R, Brown JP, Cohen A and Kim H: A practical
guide to the monitoring and management of the complications of
systemic corticosteroid therapy. Allergy Asthma Clin Immunol.
9(30)2013.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Braun J and Kay J: The safety of emerging
biosimilar drugs for the treatment of rheumatoid arthritis. Expert
Opin Drug Saf. 16:289–302. 2017.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Fox RI, Herrmann ML, Frangou CG, Wahl GM,
Morris RE and Kirschbaum BJ: How does leflunomide modulate the
immune response in rheumatoid arthritis? BioDrugs. 12:301–315.
1999.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Cohen S, Genovese MC, Choy E, Perez-Ruiz
F, Matsumoto A, Pavelka K, Pablos JL, Rizzo W, Hrycaj P, Zhang N,
et al: Efficacy and safety of the biosimilar ABP 501 compared with
adalimumab in patients with moderate to severe rheumatoid
arthritis: A randomised, double-blind, phase III equivalence study.
Ann Rheum Dis. 76:1679–1687. 2017.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Dubois EA and Cohen AF: Abatacept. Br J
Clin Pharmacol. 68(480)2009.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Yu A, Amrute JM and Eghtesady P: Review of
interleukin-6 and cardiopulmonary bypass-related end-organ injury
along with the potential for mitigation with tocilizumab. World J
Pediatr Congenit Heart Surg: Oct 25, 2024 (Epub ahead of
print).
|
|
66
|
Melo AT, Campanilho-Marques R and Fonseca
JE: Golimumab (anti-TNF monoclonal antibody): Where we stand today.
Hum Vaccin Immunother. 17:1586–1598. 2021.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Hodge JA, Kawabata TT, Krishnaswami S,
Clark JD, Telliez JB, Dowty ME, Menon S, Lamba M and Zwillich S:
The mechanism of action of tofacitinib-an oral Janus kinase
inhibitor for the treatment of rheumatoid arthritis. Clin Exp
Rheumatol. 34:318–332. 2016.PubMed/NCBI
|
|
68
|
Dogra S, Shah S, Sharma A, Chhabra S and
Narang T: Emerging role of baricitinib in dermatology practice: All
we need to know! Indian Dermatol Online J. 14:153–162.
2023.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Mohamed MEF, Bhatnagar S, Parmentier JM,
Nakasato P and Wung P: Upadacitinib: Mechanism of action, clinical,
and translational science. Clin Transl Sci.
17(e13688)2024.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Tanaka Y: The JAK inhibitors: Do they
bring a paradigm shift for the management of rheumatic diseases?
Rheumatology (Oxford). 58 (Suppl_1):i1–i3. 2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Chaiamnuay S, Allison JJ and Curtis JR:
Risks versus benefits of cyclooxygenase-2-selective nonsteroidal
antiinflammatory drugs. Am J Health Syst Pharm. 63:1837–1851.
2006.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Vane JR: Inhibition of prostaglandin
synthesis as a mechanism of action for aspirin-like drugs. Nat New
Biol. 231:232–235. 1971.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Berkes EA: Anaphylactic and anaphylactoid
reactions to aspirin and other NSAIDs. Clin Rev Allergy Immunol.
24:137–147. 2003.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Benjamin O, Goyal A and Lappin SL: Disease
modifying anti-rheumatic drugs (DMARD). In: StatPearls [Internet].
StatPearls Publishing, Treasure Island, FL, 2018.
|
|
75
|
Spies CM, Bijlsma JW, Burmester GR and
Buttgereit F: Pharmacology of glucocorticoids in rheumatoid
arthritis. Curr Opin Pharmacol. 10:302–307. 2010.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Stahn C, Löwenberg M, Hommes DW and
Buttgereit F: Molecular mechanisms of glucocorticoid action and
selective glucocorticoid receptor agonists. Mol Cell Endocrinol.
275:71–78. 2007.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Kleiman A and Tuckermann JP:
Glucocorticoid receptor action in beneficial and side effects of
steroid therapy: Lessons from conditional knockout mice. Mol Cell
Endocrinol. 275:98–108. 2007.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Thomas J, Bansback N, Barber C, Wells G
and Hazlewood G: Personalized medicine in rheumatoid arthritis:
Combining biomarkers and patient preferences to guide therapeutic
decisions. Best Pract Res Clin Rheumatol. 36(101812)2022.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Aletaha D and Smolen J: The simplified
disease activity index (SDAI) and the clinical disease activity
index (CDAI): A review of their usefulness and validity in
rheumatoid arthritis. Clin Exp Rheumatol. 23 (5 Suppl
39):S100–S108. 2005.PubMed/NCBI
|
|
80
|
Hur B, Gupta VK, Huang H, Wright KA,
Warrington KJ, Taneja V, Davis JM III and Sung J: Plasma
metabolomic profiling in patients with rheumatoid arthritis
identifies biochemical features predictive of quantitative disease
activity. Arthritis Res Ther. 23(164)2021.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Laborde CM, Castro-Santos P and Díaz-Peña
R: Contribution of multiplex immunoassays to rheumatoid arthritis
management: From biomarker discovery to personalized medicine. J
Pers Med. 10(202)2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Smolen JS, Aletaha D and McInnes IB:
Rheumatoid arthritis. Lancet. 388:2023–2038. 2016.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Isaacs JD, Burmester GR and Combe B:
Evolving concepts of pathogenesis and treatment of rheumatoid
arthritis: A review. Nat Rev Rheumatol. 18:123–136. 2022.
|
|
84
|
Asif HM, Akram M, Akhtar N, Ahmed K, Shah
SA, Riaz Rehman R and Khan MI: Rheumatoid arthritis: A review
article. International Journal of Applied Biology and
Pharmaceutical Technology. 2:108–111. 2011.
|
|
85
|
Arulselvan P, Fard MT, Tan WS, Gothai S,
Fakurazi S, Norhaizan ME and Kumar SS: Role of antioxidants and
natural products in inflammation. Oxid Med Cell Longev.
2016(5276130)2016.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Tsoupras A, Lordan R and Zabetakis I:
Inflammation, not cholesterol, is a cause of chronic disease.
Nutrients. 10(604)2018.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Yahfoufi N, Alsadi N, Jambi M and Matar C:
The immunomodulatory and anti-inflammatory role of polyphenols.
Nutrients. 10(1618)2018.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Maione F, Russo R, Khan H and Mascolo N:
Medicinal plants with anti-inflammatory activities. Nat Prod Res.
30:1343–1352. 2016.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Dash GK, Suresh P, Sahu SK, Kar DM,
Ganapaty S and Panda SB: Evaluation of evolvulus alsinoides Linn
for anthelmintic and antimicrobial activities, 2002.
|
|
90
|
Das B, Choudhury MD, Dey A, Talukdar AD,
Nongalleima KH and Deb L: Antioxidant and anti-inflammatory
activity of aqueous and methanolic extracts of rhizome part of
Drynaria quercifolia (L.). Int J Pharm Pharm Sci. 6:43–49.
2014.
|
|
91
|
Sani SA, Faik AM, Abdulla R and
Kunasekaran S: Phytochemical, antioxidant and antibacterial
activities of two kinds of Sabah Zingberaceae. J Phys Conf Ser.
1358(012012)2019.
|
|
92
|
Obiștioiu D, Hulea A, Cocan I, Alexa E,
Negrea M, Popescu I, Herman V, Imbrea IM, Heghedus-Mindru G,
Suleiman MA, et al: Boswellia essential oil: Natural antioxidant as
an effective antimicrobial and anti-inflammatory agent.
Antioxidants (Basel). 12(1807)2023.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Abdollahi E, Johnston TP, Ghaneifar Z,
Vahedi P, Goleij P, Azhdari S and Moghaddam AS: Immunomodulatory
therapeutic effects of curcumin on M1/M2 macrophage polarization in
inflammatory diseases. Curr Mol Pharmacol. 16:2–14. 2023.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Deng T, Xu J, Wang Q, Wang X, Jiao Y, Cao
X and Xiao C: Immunomodulatory effects of curcumin on macrophage
polarization in rheumatoid arthritis. Front Pharmacol.
15(1369337)2024.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Rahimi VB, Askari VR and Baeeri M:
Boswellia species in the treatment of rheumatoid arthritis:
Mechanisms and clinical evidence. J Ethnopharmacol. 312(116509,
202)2023.
|
|
96
|
Wang C, Li D, Zhang J and Yang Y:
Tripterygium wilfordii in the treatment of rheumatoid
arthritis: A meta-analysis of randomized controlled trials. J
Ethnopharmacol. 268(113573)2021.
|
|
97
|
Liu Q, Chen T, Hu Y and Zhang L:
Triptolide suppresses Th17 cell differentiation and promotes
regulatory T-cell induction via NF-κB inhibition in rheumatoid
arthritis. Front Immunol. 14(1045678)2023.
|
|
98
|
Wei K, Korsunsky I and Marshall JL:
Single-cell transcriptomics identifies fibroblast-like synoviocytes
as key therapeutic targets in rheumatoid arthritis. Nature Med.
29:482–493. 2023.
|
|
99
|
Smolen JS, Aletaha D and McInnes IB:
Biomarker-driven precision medicine in rheumatoid arthritis:
Challenges and future directions. Lancet Rheumatol. 5:e285–e295.
2023.
|
|
100
|
Chen Y, Wu H and Zhang Y: AI-driven drug
discovery for autoimmune diseases: Applications in rheumatoid
arthritis. Front Pharmacol. 15(1204897)2024.
|
|
101
|
Georgewill UO and Georgewill OA:
Antiarthritic activity of Abrus precatorius in Albino rats. J Pharm
Allied Sci. 6:2009.
|
|
102
|
Lee JH, Jung HS, Giang PM, Jin X, Lee S,
Son PT and Lee JJ: Blockade of nuclear factor-kappaB signaling
pathway and anti-inflammatory activity of cardamomin, a chalcone
analog from Alpinia conchigera. J Pharmacol Exp Ther. 316:271–278.
2006.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Manga HM, Brkic D, Marie DE and
Quetin-Leclercq J: In vivo anti-inflammatory activity of Alchornea
cordifolia (Schumach. & Thonn.) Müll. Arg.(Euphorbiaceae). J
Ethnopharmacol. 92:209–214. 2004.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Jagadeesh K, Srinivas K and Revankar SP:
Anti inflammatory effect of Azadirachta Indica (Neem) in albino
rats: An experimental study. IOSR J Pharm. 4:34–38. 2014.
|
|
105
|
Mengi SA and Deshpande SG: Evaluation of
ocular anti-inflammatory activity of Butea frondosa. Indian J
Pharmacol. 27(116)1995.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Sharma A, Bhatia S, Kharya MD, Gajbhiye V,
Ganesh N, Namdeo AG and Mahadik KR: Anti-inflammatory and analgesic
activity of different fractions of Boswellia serrata. Int J
Phytomed. 2:94–99. 2010.
|
|
107
|
Küpeli E and Yesilada E: Flavonoids with
anti-inflammatory and antinociceptive activity from Cistus
laurifolius L. leaves through bioassay-guided procedures. J
Ethnopharmacol. 112:524–530. 2007.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Chatterjee GK and Pal SD: Antiinflammatory
agents from Indian medicinal plants. Indian Drugs. 21(431)1984.
|
|
109
|
Paval J, Kaitheri SK, Potu BK, Govindan S,
Kumar RS, Narayanan SN and Moorkoth S: Anti-arthritic potential of
the plant Justicia gendarussa Burm F. Clinics (Sao Paulo).
64:357–362. 2009.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Esmat A, Al-Abbasi FA, Algandaby MM,
Moussa AY, Labib RM, Ayoub NA and Abdel-Naim AB: Anti-inflammatory
activity of Pistacia khinjuk in different experimental models:
isolation and characterization of its flavonoids and galloylated
sugars. J Med Food. 15:278–287. 2012.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Olukoga A and Donaldson D: Liquorice and
its health implications. J R Soc Promot Health. 120:83–89.
2000.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Ekambaram S, Perumal SS and Subramanian V:
Evaluation of antiarthritic activity of Strychnos potatorum Linn
seeds in Freund's adjuvant induced arthritic rat model. BMC
Complement Altern Med. 10(56)2010.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Abudoleh S, Disi A, Qunaibi E and Aburjai
T: Anti-arthritic activity of the methanolic leaf extract of
Urtica pilulifera L. on albino rats. Am J Pharmacol Toxicol.
6:27–32. 2011.
|
|
114
|
Diggle PK, Meixner MA, Carroll AB and
Aschwanden CF: Barriers to sexual reproduction in Polygonum
viviparum: A comparative developmental analysis of P. viviparum and
P. bistortoides. Ann Bot. 89:145–156. 2002.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Marri Praveen MP and Janarthan M:
Evaluation of anti arthritic activity of aqueous extract of
Hibiscus platinifolius in albino rats. IJRPB. 2013:815–818.
2013.
|
|
116
|
Hemlatha K and Satyanarayana D:
Anti-inflammatory activity of Annona squamosa Linn. Biomed
Pharmacol J. 2:17–20. 2015.
|
|
117
|
Dragos D, Gilca M, Gaman L, Vlad A, Iosif
L, Stoian I and Lupescu O: Phytomedicine in joint disorders.
Nutrients. 9(70)2017.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Aziz DZ, Kadhim NJ, Majeed AA and Abood
AH: Protective Effects of Ginger extract against Methotrexate
induced cytotoxicity in mice. J Phys Conf Ser.
1664(012103)2020.
|
|
119
|
Xia X, May BH, Zhang AL, Guo X, Lu C, Xue
CC and Huang Q: Chinese herbal medicines for rheumatoid arthritis:
Text-mining the classical literature for potentially effective
natural products. Evid Based Complement Alternat Med.
2020(7531967)2020.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Ammar NM, Al-Okbi SY and Mohamed DA: Study
of the anti-inflammatory activity of some medicinal edible plants
growing in Egypt. Med J Islamic World Acad Sci. 10:113–122.
1997.
|
|
121
|
Amri O, Zekhnini A, Bouhaimi A, Tahrouch S
and Hatimi A: Anti-inflammatory activity of methanolic extract from
Pistacia atlantica Desf. leaves. Pharmacogn J. 10:71–76. 2018.
|
|
122
|
Sagnia B, Fedeli D, Casetti R, Montesano
C, Falcioni G and Colizzi V: Antioxidant and anti-inflammatory
activities of extracts from Cassia alata, Eleusine indica,
Eremomastax speciosa, Carica papaya and Polyscias fulva medicinal
plants collected in Cameroon. PLoS One. 9(e103999)2014.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Jäger AK, Hutchings A and van Staden J:
Screening of Zulu medicinal plants for prostaglandin-synthesis
inhibitors. J Ethnopharmacol. 52:95–100. 1996.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Oguntibeju OO: Medicinal plants with
anti-inflammatory activities from selected countries and regions of
Africa. J Inflamm Res. 11:307–317. 2018.PubMed/NCBI View Article : Google Scholar
|
